ArticlePediatric research2026
Circulating microRNAs in preterm white matter injury: a systems biology/qPCR-based pilot study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhite matter injury (WMI) is a major cause of neurodevelopmental impairment in preterm infants (PTIs), yet early molecular biomarkers remain elusive. Circulating microRNAs (miRNAs) hold promise, but neonatal biosample limitations challenge the use of high-throughput methods like next-generation sequencing (NGS). We evaluated the feasibility of quantitative PCR (qPCR) as a primary discovery tool for circulating miRNA biomarkers of WMI, supported by systems biology modeling and selective NGS validation.
methodsPlasma-derived miRNAs from PTIs with and without WMI were profiled using qPCR after stringent hemolysis screening. Candidate miRNAs were curated from brain-specific regulatory networks. ROC bootstrapping and gene ontology/pathway enrichment were used to assess diagnostic and functional relevance. Boolean logic modeling simulated miRNA-mediated regulation of oligodendrocyte maturation.
resultsmiR-23a-3p and miR-17-5p were differentially expressed across WMI states and showed moderate discriminative power (AUCs: 0.71 and 0.68), while oligodendrocyte miRNAs (miR-219a-2-3p, miR-338-5p) were consistently low. Boolean simulations confirmed miR-23a and miR-17 modulate myelination via PTEN repression and PI3K/Akt pathway activation. qPCR and model predictions aligned strongly; NGS showed discordant trends likely due to detection biases.
conclusionThis pilot study demonstrates that qPCR, when combined with systems modeling, proposes a viable and sensitive discovery tool for miRNA biomarkers in clinically constrained populations. IMPACT: This study demonstrates that qPCR combined with systems biology modeling, is a viable and biologically coherent approach for identifying circulating miRNA biomarkers of white matter injury in preterm infants. It challenges the conventional reliance on next-generation sequencing as the default discovery platform, and repositions qPCR as a powerful primary discovery method for diagnostic miRNA biomarkers when coupled with systems biology modeling, showing that qPCR can yield translational insights in ethically and clinically constrained neonatal populations. By integrating Boolean logic simulations, the study links key miRNAs (miR-23a-3p and miR-17-5p) to mechanistic pathways of oligodendrocyte maturation, offering a functional layer to biomarker discovery.
Identifiers
41917424What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.